Arla Foods Ingredients has launched Lacprodan CGMP-30, a new casein glycomacropeptide (CGMP) with significantly reduced levels of phenylalanine, by around 50%, compared to its predecessor, Lacprodan CGMP-20. The supplier highlights that the ingredient is particularly suitable for patients sensitive to the amino acid phenylalanine, which is naturally abundant in dietary proteins. The alternative offers the same benefits as Lacprodan CGMP-20, which already contains very low levels of phenylalanine to address dietary challenges associated with phenylketonuria.
